A. Gafni et al., INDUCTION OF LABOR VERSUS EXPECTANT MANAGEMENT FOR PRELABOR RUPTURE OF THE MEMBRANES AT TERM - AN ECONOMIC-EVALUATION, CMAJ. Canadian Medical Association journal, 157(11), 1997, pp. 1519-1525
Background: As the interval between rupture of the fetal membranes at
term and delivery increases, so may the risk of fetal and maternal inf
ection. Recently the TERMPROM (Term Prelabor Rupture of the Membranes)
Study Group reported the results of a randomized controlled trial com
paring 4 management strategies: induction with oxytocin (IwO), inducti
on with prostaglandin (IwP), and expectant management and induction wi
th either oxytocin (EM-O) or prostaglandin (EM-P) if complications dev
eloped. The study found no statistically significant differences in ne
onatal infection and cesarean section rates between any of the 4 group
s. Objective: To conduct an economic evaluation comparing the cost of
(a) IwO and EM-O, (b) IwP and EM-P and (c) IwO and IwP. Design: An eco
nomic analysis, conducted alongside the clinical trial, using a third-
party payer perspective. Analysis included all treatment costs incurre
d for both the mother and the baby. information on health care utiliza
tion and outcomes was collected for all study participants. Three coun
tries (Canada, the United Kingdom and Australia), corresponding to the
largest study recruitment, were chosen for calculation of unit costs.
For each country, the base, low and high estimates of unit cost for e
ach service item were generated. Intention-to-treat analysis. Extensiv
e statistical and sensitivity analyses were performed. Results: The me
dian cost of IwO per patient was significantly lower statistically tha
n that of EM-O and IwP. This result held in all 3 countries compared (
-$114 and -$46 in Canada, -pound 113 and -pound 63 in the UK, and -A$3
0 and -A$49 in Australia) and after an extensive sensitivity analysis.
There was no statistically significant difference in median cost per
patient between IwP and EM-P. Conclusion: Although the clinical result
s of the TERMPROM study did not find IwO to be preferable to the other
treatment alternatives, the economic evaluation found it to be less c
ostly. However, these cost differences, even though statistically sign
ificant, are not likely to be important in many countries. When this i
s the case, the authors recommend that women be offered a choice betwe
en management strategies.